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Abstract

Literature Review

• Breast cancer screening imaging options have progressed greatly over
•
the years in sensitivity, specificity, and image quality. According to
DynaMed Plus, in 2012 there were 522,000 deaths by breast cancer and
1,677,000 total cases of breast cancer documented (Dynamed, 2018). For
years, traditional screening for breast cancer involved 2D digital
mammography which obtains two views of each breast. With advances in
technology, the use of 3D breast tomosynthesis has become an
advantageous addition to routine breast cancer screening protocols at
many health care facilities.
• My literature review of articles was found in PubMed, DynaMed Plus,
Cochrane Library, and Clinical Key from the year 2011 and on. The
benefits of 2D digital mammography alone, 3D breast tomosynthesis
alone, and 2D digital mammography combined with 3D breast
tomosynthesis are compared. This study also compares the differences in
radiation dose of each imaging option. The research demonstrated that 2D
digital mammography combined with 3D breast tomosynthesis offers the
•
lowest recall rates, the highest sensitivity and specificity, and increases
the effectiveness of breast cancer screening.
• Key Terms: breast cancer screening, age 40 and older, 2D mammography,
3D mammography, and radiation dose mammography.

Introduction
• 2D digital mammography has been considered the gold standard for
breast cancer screening (Dynamed, 2018). Each healthcare facility
develops its own protocol for breast cancer screening. Some facilities
have the resources to combine 2D digital mammography with 3D breast
tomosynthesis in one imaging system.
• 2D digital mammography consists of two views of each breast under
compression. 3D breast tomosynthesis consists of the same views under
compression for each breast. During 3D breast tomosynthesis, the patient
is under compression while the machine moves in a semi-circular pattern
to obtain many views from different angles. While the machine rotates
around the breast obtaining these different views, it is ultimately capable
of imaging the breast tissue with minimal superimposition. This is very
helpful in patients who have dense breast tissue in which cancer can
easily hide. The digital ability of the 3D breast tomosynthesis machine
reconstructs the two views that are normally obtained by 2D digital
mammography. There is question as to whether the reconstructed views
obtained by 3D breast tomosynthesis are diagnostically comparable to
those obtained by 2D digital mammography.
• The purpose of this study is to compare the specificity, sensitivity, and
radiation dose of 2D digital mammography alone, 3D breast
tomosynthesis alone, and 2D digital mammography combined with 3D
breast tomosynthesis. This study involves screening in women age 40 and
older for breast cancer. The sensitivity and specificity of the imaging
options weighs heavily on whether a patient is called back for further
imaging, studies, or procedures.
• Reducing the number of call backs for patients is beneficial to the patients,
their loved ones, and the institution in which the patient doctors.

•

Statement of the Problem
• When a patient receives a 3D breast tomosynthesis scan, it can
reconstruct images that a 2D digital mammography scan would provide.
This could ultimately eliminate the need for 2D digital mammography.
Further investigation is needed to determine the specificity, sensitivity, and
radiation dose of 2D digital mammography, 3D breast tomosynthesis, and
these studies combined. This will help determine the safest and most
effective imaging protocol for screening of breast cancer as this is an
annual recommendation.

Research Question
• In women age 40 and older, does screening for breast cancer using 3D
breast tomosynthesis alone versus 2D digital mammography alone offer
increased accuracy, specificity, sensitivity, and less call back tests for
patients?
• In women age 40 and older, does screening for breast cancer using
combination of 2D digital mammography with 3D breast tomosynthesis
versus 2D digital mammography alone or 3D breast tomosynthesis alone
offer increased accuracy, specificity, sensitivity, and less call back tests for
patients?

•

Current screening recommendations and imaging options for breast
cancer
– At least every two years for average-risk women aged 50-74.
Patients offered screening at age 40; this is based on shared
decision making. Mammography is the imaging of choice for patients
with average-risk of breast cancer. (Dynamed, 2018).
• A limitation to this study is that it does not discuss the radiation
doses of each imaging modality.
– The American College of Radiology (ACR) Appropriateness Criteria
for Breast Cancer Screening recommends annual screening
mammography or 3D breast tomosynthesis for average-risk women
age 40 and older (Mainiero et al., 2017).
• A limitation to this study is the lack of evidence of cancer
detection rates in each imaging modality.
Comparing 2D digital mammography alone and 3D breast tomosynthesis
(with 2D reconstruction) alone
– Recall rate for 3D breast tomosynthesis was 3.0% and 3.6% for 2D
digital mammography (Aase et al., 2018).
• There were a moderate number of cases included in the study
which represents a limitation especially when stratifying into
subgroups.
– Recall rate for women with dense breasts was 2.2% for 3D breast
tomosynthesis and 3.4% for 2D digital mammography (Aase et al.,
2018).
– Sensitivity, specificity, PPV, and NPV of 3D breast tomosynthesis
(0.93, 0.75, 0.64, 0.96) were higher than 2D digital mammography
(0.90, 0.56, 0.49, 0.92). It was concluded that there was a significant
reduction in the need for additional views with 3D breast
tomosynthesis (Mall et al., 2018)
• Limitation of the study is the fact that 144 participants is relatively
small.
Comparing 2D digital mammography combined with 3D breast
tomosynthesis
– There was an increase in cancer detection for 3D breast
tomosynthesis plus 2D digital mammography than 2D digital
mammography alone for invasive cancer, stage T1, nodal-negative,
all histologic grades, and histologic types of invasive cancer.
Combining 3D breast tomosynthesis with 2D digital mammography
did not increase detection of carcinoma in situ or nodal-positive
cancer. (Yun et al., 2017).
• A limitation to this study is that the radiation doses were not
included based on the lack of evidence they were able to find
from the studies selected to review.
– Detection rate was about 90% higher with 3D breast tomosynthesis
combined with 2D digital mammography then with 2D digital
mammography alone (Pattacini et al., 2018).
• A limitation was that the study’s read time was estimated for
digital mammography and for digital breast tomosynthesis but not
for theses studies combined as this occurred after reading digital
breast tomosynthesis alone.
Comparison of radiation doses between 2D digital mammography alone,
3D breast tomosynthesis alone, and 2D digital mammography combined
with 3D breast tomosynthesis
– Estimated mean glandular dose (per view) was 1.36mGy for 2D
digital mammography, 1.87mGy for 3D breast tomosynthesis, and
3.22mGy for a combination study (Gennaro et al., 2017).
• The examinations were all performed on the same system
(Selenia Dimensions Hologic) which allows the study to be stable
in terms of radiation dose delivered but this is also a limitation
because different systems deliver a slightly different dosage.
– Estimated mean glandular dose for 3D breast tomosynthesis was
2.96mGy and 2.95mGy for 2D digital mammography (Aase et al.,
2018)
– Physicists work with imaging systems purchased by a health care
facility in order to calibrate them appropriately.

Discussion
•

•

In women age 40 and older, does screening for breast cancer using 3D
breast tomosynthesis alone versus 2D digital mammography alone offer
increased accuracy, specificity, sensitivity, and less call back tests for
patients?
– Mall et al. (2018) reported that 3D breast tomosynthesis demonstrates
increased sensitivity, specificity, positive predictive value, and negative
predictive value when compared to 2D digital mammography. It also
included that radiologists had improved performance when reading 3D
breast tomosynthesis compared to 2D digital mammography. In
conclusion of the study conducted by Mall et al. (2018), 3D breast
tomosynthesis is superior to 2D digital mammography and reduces the
need for additional views which increases the patient’s radiation
exposure.
– According to Gennaro et al. (2017) and Mainiero et al. (2018), there is
only a modest increase in radiation dose when replacing 2D digital
mammography with 3D breast tomosynthesis. It is important to mention
that the radiation dose is different for each imaging system used and
depends on how the machine is calibrated by the facility’s physicists.
In women age 40 and older, does screening for breast cancer using
combination of 2D digital mammography with 3D breast tomosynthesis
versus 2D digital mammography alone or 3D breast tomosynthesis alone
offer increased accuracy, specificity, sensitivity, and less call back tests
for patients?
– When 3D breast tomosynthesis is combine with 2D digital
mammography instead of digitally constructing the views obtained by
2D digital mammography, this results in higher invasive cancer
detection rates and increased effectiveness of breast cancer screening
making it the superior screening protocol (Hodgson et al., 2016).
– Overall, the review of the literature demonstrates that the combination
of 3D breast tomosynthesis and 2D digital mammography provides the
most accurate detection of breast cancer and the highest specificity,
sensitivity, positive predictive value, negative predictive value, and the
lowest recall rate for further imaging. The only risk and negative side to
this combination being standard screening, is a modest increase in
radiation dose and a slight increase in time that the patient is under
compression.
Figure 1: 70-year-old woman’s imaging comparing FFDM (2D digital
mammography) with DBT (3D breast tomosynthesis). This demonstrates the
imaging quality of invasive ductal carcinoma in craniocaudal views accompanied by
correlating magnification views.
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Applicability to Clinical Practice
• When 3D breast tomosynthesis is combined with 2D digital
mammography, the rate of patients who got called back for further imaging
were lower than the rate compared to 2D digital mammography alone and
3D breast tomosynthesis alone. The greatest benefit of 3D breast
tomosynthesis is the technology it uses to look at tissue in the breast
without superimposition. This increase in specificity and sensitivity saves
the patient from unnecessary anxiety, time taken out of their daily lives,
and increased cost to the patient and healthcare facility. There have been
instances where 3D breast tomosynthesis has saved a patient from
addition procedures that, in some cases, can be invasive. This is
especially important and significant in women with dense breast tissue.
Cancer hides easily in dense breast tissue on 2D digital mammography.
• Some studies reported a slight increase in radiation dose when combining
3D breast tomosynthesis with 2D digital mammography while other
studies did not report an increase in radiation. The radiation dose depends
on the imaging system and the physicists who work together to calibrate
the system in order to deliver a radiation dose as low as reasonably
achievable. There are some imaging systems in which there is no
increase in radiation dose when 3D breast tomosynthesis is combined
with 2D digital mammography. This information is incredibly valuable to
providers when ordering screening mammography studies for women.
When a patient expresses concern about the added radiation or added
compression they will undergo, the information included in this literature
review helps to better explain the mammographic study including the risks
and benefits
• If a health care facility’s protocol for breast cancer screening involves 3D
breast tomosynthesis combined with 2D digital mammography, evidence
in this literature review shows that this offers the most accurate and safest
imaging option for breast cancer screening in women 40 and older.
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